FIT 039

Drug Profile

FIT 039

Alternative Names: FIT039

Latest Information Update: 18 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kino Pharma
  • Class Antivirals
  • Mechanism of Action Cyclin dependent kinase 9 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Warts

Most Recent Events

  • 08 Nov 2017 Kyoto University Hospital plans a phase I/II trial for Warts in Japan (UMIN000029695)
  • 01 Jan 2016 Phase-I/II clinical trials in Warts in Japan (Topical) (UMIN000019866)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top